PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.55%
Revenue growth at 50-75% of MRVL's 4.29%. Martin Whitman would worry about competitiveness or product relevance.
1.98%
Gross profit growth at 50-75% of MRVL's 3.82%. Martin Whitman would question if cost structure or brand is lagging.
-0.34%
Negative EBIT growth while MRVL is at 8.09%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.34%
Negative operating income growth while MRVL is at 15.99%. Joel Greenblatt would press for urgent turnaround measures.
1.09%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
8.33%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
8.33%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.53%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.43%
Diluted share reduction more than 1.5x MRVL's 1.17%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
28.73%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
36.43%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
170.27%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
75.71%
10Y revenue/share CAGR 1.25-1.5x MRVL's 56.20%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
25.80%
5Y revenue/share CAGR under 50% of MRVL's 109.65%. Michael Burry would suspect a significant competitive gap or product weakness.
21.91%
3Y revenue/share CAGR at 75-90% of MRVL's 25.49%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32045.29%
3Y OCF/share CAGR above 1.5x MRVL's 63.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
282.66%
Below 50% of MRVL's 653.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
115.17%
5Y net income/share CAGR at 50-75% of MRVL's 220.76%. Martin Whitman might see a shortfall in operational efficiency or brand power.
232.45%
3Y net income/share CAGR 1.25-1.5x MRVL's 202.86%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
-12.64%
Negative 5Y equity/share growth while MRVL is at 19.67%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
7.50%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
32.23%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-78.93%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
0.83%
AR growth is negative/stable vs. MRVL's 11.24%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-1.58%
Inventory is declining while MRVL stands at 4.05%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.49%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.43%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-6.04%
We’re deleveraging while MRVL stands at 3.89%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.61%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.